Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.earumpharma.com | |
Market Cap | 24.22 Cr. | |
Enterprise Value(EV) | 32.93 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.06 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 17.46 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 38.89 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 2.25 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 0.44 | Calculated using Price: 0.98 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 24.71 Cr. | 247,111,618 Shares |
FaceValue | 2 | |
About Earum Pharmaceuticals Ltd. | ||
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API's) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc. |
1 Day |
|
|
1 Week |
|
-2.97% |
1 Month |
|
-13.27% |
3 Month |
|
-2.97% |
6 Month |
|
-52.88% |
1 Year |
|
-55.66% |
2 Year |
|
-91.33% |
5 Year |
|
|
10 Year |
|
8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 7.15 | 11.05 | 30.94 | 32.17 | 17.83 | 0.61 | 14.24 | 11.18 | |
Return on Capital Employed (%) | 17.10 | 21.97 | 24.94 | 23.99 | 17.40 | 4.23 | 12.34 | 11.66 | |
Return on Assets (%) | 1.11 | 1.61 | 5.98 | 7.77 | 6.11 | 0.28 | 7.85 | 6.91 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 1 | 2 | 5 | 6 | 14 | 15 | 17 | 19 | |
Non Curr. Liab. | 0 | 1 | 2 | 3 | 1 | 2 | 0 | 0 | |
Curr. Liab. | 7 | 9 | 13 | 15 | 20 | 11 | 12 | 10 | |
Minority Int. | |||||||||
Equity & Liab. | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | |
Non Curr. Assets | 0 | 0 | 0 | 0 | 4 | 1 | 1 | 0 | |
Curr. Assets | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | |
Misc. Exp. not W/O | |||||||||
Total Assets | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 12 | |
Other Income | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 2 | |
Total Income | 19 | 24 | 36 | 51 | 57 | 50 | 29 | 16 | 14 | |
Total Expenditure | -18 | -23 | -34 | -47 | -54 | -49 | -25 | -13 | -11 | |
PBIDT | 1 | 1 | 2 | 3 | 4 | 1 | 3 | 3 | 3 | |
Interest | 0 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | -1 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | -1 | -1 | 0 | -1 | -1 | -1 | |
Exceptional Items | ||||||||||
PAT | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 1 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -7 | 0 | -3 | -7 | 3 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | -3 | 3 | 0 | ||
Cash Fr. Finan. | 1 | 0 | 7 | 1 | 7 | 3 | -3 | 0 | |
Net Change | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
Fri, 13 Oct 2023
Reg. 34 (1) Annual Report. Kindly find the attached Annual Report of the Company. |
Tue, 10 Oct 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Kindly find attached compliance certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulations 2018. |
Sat, 30 Sep 2023
Closure of Trading Window Kindly find the attached intimation for closure of trading window. |
Thu, 07 Dec 2023 |
|
|
|
|
|